Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Sites / Massachusetts General Hospital / Gillette, Michael

Gillette, Michael (M.D., Ph.D.)

Staff, Massachusetts General Hospital, 617-714-9743

Contact Information

Email: mailto:gillette@broadinstitute.org
Fax:
Co-Investigator

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
Proteomic Genetic and Longitudinal Pathways to Ovarian Cancer Biomarkers 0 0
Uterine Lavage 0 0
Validation of Early Detection Ovarian Cancer Biomarkers (Team Project) 149 0
Benign Breast Disease Team Project 0 0
DCIS Team Project 0 0

Closed Protocols

No closed protocols.

Publications

Publication Name PubMed ID Journal
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. 21372036 Cancer Prev Res (Phila)
Development of a multimarker assay for early detection of ovarian cancer. 20368574 J. Clin. Oncol.
Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. 20471625 Am. J. Obstet. Gynecol.
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders. 22284961 Am. J. Obstet. Gynecol.
Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers. 22543921 Int. J. Gynecol. Cancer
Ovarian cancer screening: development of the risk of ovarian cancer algorithm (ROCA) and ROCA screening trials. 22543916 Int. J. Gynecol. Cancer
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. 21372037 Cancer Prev Res (Phila)

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Addresses

7 Cambridge Center
Massachusetts General Hospital

To update addresses, please visit the Data Management and Coordinating Center.

Announcement 10/23/2017

Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.

32nd SC Meeting
Thank you to everyone who made the 32nd EDRN Steering Committee meeting a success. The next event is the 10th EDRN Scientific Workshop from March 6-8, 2018 in Bethesda, MD. More information about this Workshop will be sent soon. Click here to view the flyer.
EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.